119 related articles for article (PubMed ID: 479438)
1. Immune derangement in patients with malignant melanoma.
Lewis MG; Phillips TM; Noble PB; Hartmann DP
J Cutan Pathol; 1979 Jun; 6(3):201-7. PubMed ID: 479438
[TBL] [Abstract][Full Text] [Related]
2. Antibodies and anti-antibodies in human malignancy: an expression of deranged immune regulation.
Lewis MG; Hartman D; Jerry LM
Ann N Y Acad Sci; 1976; 276():316-27. PubMed ID: 1088385
[No Abstract] [Full Text] [Related]
3. Immunologic changes in regional lymph nodes of melanoma patients.
Hammer C; Lewis MG; Rowden G; Phillips T
Chir Forum Exp Klin Forsch; 1978; (1978):235-8. PubMed ID: 313322
[TBL] [Abstract][Full Text] [Related]
4. Immune complexes in human melanoma: a consequence of deranged immune regulation.
Jerry LM; Rowden G; Cano PO; Phillips TM; Deutsch GF; Capek A; Hartmann D; Lewis MG
Scand J Immunol; 1976; 5(6-7):845-59. PubMed ID: 981971
[TBL] [Abstract][Full Text] [Related]
5. Plasma membrane and internalized immunoglobulins of lymph node cells studied with conjugates of antibody or its Fab fragments with horseradish peroxidase.
Antoine JC; Avrameas S; Gonatas NK; Stieber A; Gonatas JO
J Cell Biol; 1974 Oct; 63(1):12-23. PubMed ID: 4608522
[TBL] [Abstract][Full Text] [Related]
6. Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.
Mortarini R; Piris A; Maurichi A; Molla A; Bersani I; Bono A; Bartoli C; Santinami M; Lombardo C; Ravagnani F; Cascinelli N; Parmiani G; Anichini A
Cancer Res; 2003 May; 63(10):2535-45. PubMed ID: 12750277
[TBL] [Abstract][Full Text] [Related]
7. The effect of anti-immunoglobulin antibodies of Fc rosettes.
Krammer PH; Pernis B
Scand J Immunol; 1976; 5(3):199-204. PubMed ID: 1084014
[TBL] [Abstract][Full Text] [Related]
8. The association of alpha2-macroglobulin with lymphocyte membranes in chronic lymphocytic leukaemia and other disorders.
James K; Tunstall AM; Parker AC; McCormick JN
Clin Exp Immunol; 1975 Feb; 19(2):237-49. PubMed ID: 55322
[TBL] [Abstract][Full Text] [Related]
9. Human lymph node lymphocytes fail to effect lysis of antibody-coated target cells.
O'Toole C; Saxon A; Bohrer R
Clin Exp Immunol; 1977 Jan; 27(1):165-71. PubMed ID: 300304
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of CD8+ T cells from tumor-invaded and tumor-free lymph nodes of melanoma patients: role of common gamma-chain cytokines.
Anichini A; Scarito A; Molla A; Parmiani G; Mortarini R
J Immunol; 2003 Aug; 171(4):2134-41. PubMed ID: 12902520
[TBL] [Abstract][Full Text] [Related]
11. Detection of cell surface and intracellular antigens by human monoclonal antibodies. Hybrid cell lines derived from lymphocytes of patients with malignant melanoma.
Houghton AN; Brooks H; Cote RJ; Taormina MC; Oettgen HF; Old LJ
J Exp Med; 1983 Jul; 158(1):53-65. PubMed ID: 6864164
[TBL] [Abstract][Full Text] [Related]
12. Antigen receptors on lymphocytes.
Unanue ER; Engers HD; Karnovsky MJ
Fed Proc; 1973 Jan; 32(1):44-7. PubMed ID: 4119365
[No Abstract] [Full Text] [Related]
13. Localization of 131I-labeled p97-specific Fab fragments in human melanoma as a basis for radiotherapy.
Larson SM; Carrasquillo JA; Krohn KA; Brown JP; McGuffin RW; Ferens JM; Graham MM; Hill LD; Beaumier PL; Hellström KE
J Clin Invest; 1983 Dec; 72(6):2101-14. PubMed ID: 6196380
[TBL] [Abstract][Full Text] [Related]
14. Immunosuppression by melanoma cells as a factor in the generation of metastatic disease.
Cochran AJ; Wen DR; Farzad Z; Stene MA; McBride W; Lana AM; Hoon DS; Morton DL
Anticancer Res; 1989; 9(4):859-64. PubMed ID: 2683997
[TBL] [Abstract][Full Text] [Related]
15. Nature of antigens and antibodies in immune complexes isolated by staphylococcal protein A from plasma of melanoma patients.
Gupta RK; Leitch AM; Morton DL
Cancer Immunol Immunother; 1983; 16(1):40-7. PubMed ID: 6556950
[TBL] [Abstract][Full Text] [Related]
16. Role of membrane structures in B-lymphocyte activation. The effect of binding anti-immunoglobulin, aggregated IgG and immune complexes.
Ramasamy R
Immunology; 1976 Apr; 30(4):559-64. PubMed ID: 1083830
[TBL] [Abstract][Full Text] [Related]
17. Isolation and immunochemical characterization of antibodies from the sera of cancer patients which are reactive against human melanoma cell membranes by affinity chromatography.
Gupta RK; Silver HK; Reisfeld RA; Morton DL
Cancer Res; 1979 May; 39(5):1683-95. PubMed ID: 427806
[TBL] [Abstract][Full Text] [Related]
18. Beneficial and detrimental effects of humoral immunity in malignancy.
Lewis MG; Philips TM; Rowden G
Pathobiol Annu; 1978; 8():217-39. PubMed ID: 364374
[No Abstract] [Full Text] [Related]
19. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
20. Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase.
LaTemple DC; Abrams JT; Zhang SY; Galili U
Cancer Res; 1999 Jul; 59(14):3417-23. PubMed ID: 10416604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
